X
AMRX icon

Xponance’s Amneal Pharmaceuticals AMRX Stock Holding History

Xponance’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218K Buy
17,556
+5,706
+48% +$76.6K ﹤0.01% 1432
2025
Q4 		$149K Sell
11,850
-450
-4% -$5.15K ﹤0.01% 1428
2025
Q3 		$123K Sell
12,300
-626
-5% -$5.62K ﹤0.01% 1427
2025
Q2 		$105K Sell
12,926
-257
-2% -$1.94K ﹤0.01% 1407
2025
Q1 		$110K Buy
13,183
+1,828
+16% +$15.3K ﹤0.01% 1333
2024
Q4 		$89.9K Buy
11,355
+961
+9% +$8.06K ﹤0.01% 1377
2024
Q3 		$86.5K Buy
10,394
+180
+2% +$1.41K ﹤0.01% 1328
2024
Q2 		$64.9K Buy
+10,214
New +$64.8K ﹤0.01% 1269

Other funds holding AMRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return